AnalystsSteve SeedhouseSteve Seedhouse's Stock Forecasts
AnalystsSteve Seedhouse
Sectors:
Analyst Ranking
Bottom 15%
#4475 out of 5217 analysts
Average Return
-3.03%
Win Rate
41%7 out of 17
Risk vs Reward
Poor
Good
Steve Seedhouse's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Camp4 Therapeutics CorpCAMP | +81.54% | $2.98 | $5.41 | 2025-10-01 - 2026-03-13 | Strong Buy |
Belite Bio IncBLTE | +20.67% | $136.00 | $164.11 | 2025-11-23 - 2026-03-13 | Strong Buy |
Innoviva IncINVA | +17.37% | $18.77 | $22.03 | 2025-07-10 - 2026-03-13 | Strong Buy |
Korro Bio IncKRRO | +9.50% | $11.69 | $12.80 | 2026-01-27 - 2026-03-13 | Strong Buy |
Innoviva IncINVA | +7.05% | $20.58 | $22.03 | 2025-11-05 - 2026-03-13 | Strong Buy |
Steve Seedhouse Analyst Color
Get additional color on Steve Seedhouse's coverage of popular stocks
Steve Seedhouse's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Korro Bio IncKRRO | 2 | Strong Buy | $22.00 | +71.88% | Maintains | a day ago |
Harrow IncHROW | 2 | Strong Buy | $91.00 | +166.86% | Maintains | 10 days ago |
Belite Bio IncBLTE | 2 | Strong Buy | $266.00 | +62.09% | Maintains | 11 days ago |
Surrozen IncSRZN | 1 | Strong Buy | $40.00 | +58.67% | Initiates Coverage On | 23 days ago |
Wave Life Sciences LtdWVE | 2 | Strong Buy | $41.00 | +214.90% | Maintains | a month ago |
Apellis Pharmaceuticals IncAPLS | 2 | Strong Buy | $35.00 | +84.79% | Maintains | 2 months ago |
Xencor IncXNCR | 2 | Strong Buy | $42.00 | +250.00% | Maintains | 4 months ago |
Innoviva IncINVA | 2 | Strong Buy | $31.00 | +40.72% | Maintains | 4 months ago |
Camp4 Therapeutics CorpCAMP | 1 | Strong Buy | $7.00 | +29.39% | Initiates Coverage On | 5 months ago |
Tvardi Therapeutics IncTVRD | 1 | Strong Buy | $52.00 | +1,226.53% | Initiates Coverage On | 8 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.